Indaptus Therapeutics earnings were -$15.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest INDP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$4.1M, up 34.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INDP reported annual earnings of -$15.0M, with -2.6% growth.
Indaptus Therapeutics Earnings Reports & History FAQ
What were Indaptus Therapeutics's earnings last quarter?
Indaptus Therapeutics (NASDAQ: INDP) reported Q4 2024 earnings per share (EPS) of -$0.38, up 19.15% year over year. Total INDP earnings for the quarter were -$4.13 million. In the same quarter last year, Indaptus Therapeutics's earnings per share (EPS) was -$0.47.
Is Indaptus Therapeutics profitable or losing money?
As of the last Indaptus Therapeutics earnings report, Indaptus Therapeutics is currently losing money. Indaptus Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$15.02 million, a 2.6% decrease year over year.
What was INDP's earnings growth in the past year?
As of Indaptus Therapeutics's earnings date in Q2 2025, Indaptus Therapeutics's earnings has grown year over year. INDP earnings in the past year totalled -$15.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.